Pharmaids Pharmaceuticals (BSE 524572)₹30.00+5.01%Pharmaceuticals
At the end of the Jun 2026 quarter, Pharmaids Pharmaceuticals' shareholders were: promoters 32.95%, public 67.05%. Promoter holding is unchanged on the quarter. It had 8,635 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 9.66% | 9.21% | 5.60% | 5.52% | 5.16% | 5.19% | 5.19% | 5.11% | 32.95% | 32.95% | 32.95% | 32.95% |
| Public | 90.34% | 90.79% | 94.40% | 94.48% | 94.84% | 94.81% | 94.81% | 94.89% | 67.05% | 67.05% | 67.05% | 67.05% |
| Number of shareholders | 7,396 | 7,284 | 7,570 | 7,597 | 8,052 | 8,352 | 8,223 | 8,029 | 8,030 | 8,291 | 8,409 | 8,635 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Shankarappa Nagaraja Vinaya Babu | Promoter | 28.58% | 0.00 |
| Shreedhara Shetty | Public | 14.54% | 0.00 |
| Gokaram Ramkrishna Balaji | Public | 8.04% | 0.00 |
| Smitha Shetty Sachit Shetty | Public | 7.74% | 0.00 |
| Tumkur Trade Center Private Limited | Promoter | 4.42% | 0.00 |
| Venkata Rao Sadhanala | Public | 4.29% | 0.00 |
| Makam Sreevalli | Public | 2.22% | 0.00 |
| Venu Madhava Kaparthy | Public | 2.04% | 0.00 |
| Venkatesh Mahendra | Public | 1.23% | 0.00 |
| Kant Rao | Promoter | 0.02% | 0.00 |
| B. Venkatswamy | Promoter | 0.00% | 0.00 |
Promoters held 32.95% of Pharmaids Pharmaceuticals at the end of the Jun 2026 quarter, up 27.84 percentage points from 5.11% a year earlier.
Pharmaids Pharmaceuticals had 8,635 shareholders at the end of the Jun 2026 quarter, against 8,029 a year earlier.
Shreedhara Shetty (Public) held 14.54% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.